Docoh
Loading...

AMRX Amneal Pharmaceuticals

APP
Utility
Muco-adhesive, Controlled Release Formulations of Levodopa And/or Esters of Levodopa and Uses Thereof
4 Nov 21
The invention provides an oral solid formulation comprising (a) a controlled release component comprising a core comprising levodopa, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric polymer; and (b) an immediate release component comprising carbidopa and levodopa.
Ann Hsu, Liang Dong, Amy Ding, Suneel Gupta
Filed: 10 Jul 21
APP
Utility
Muco-adhesive, Controlled Release Formulations of Levodopa And/or Esters of Levodopa and Uses Thereof
6 May 21
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
Ann Hsu, Liang Dong, Amy Ding, Suneel Gupta
Filed: 13 Jan 21
GRANT
Utility
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
27 Apr 21
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and (b) a decarboxylase inhibitor component.
Ann Hsu, Liang Dong, Amy Ding, Suneel Gupta
Filed: 17 Sep 19
GRANT
Utility
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
13 Apr 21
The invention provides a controlled release oral solid formulation comprising (a) a controlled release component comprising core comprising levodopa and/or an ester of levodopa or salts thereof, wherein the core is coated with a layer of a muco-adhesive polymer and externally coated with a layer of an enteric coated polymer; and a method of using the controlled release oral solid formulation to treat Parkinson's disease or primary parkinsonism.
Ann Hsu, Liang Dong, Amy Ding, Suneel Gupta
Filed: 1 May 20
  • 1
Patents are sorted by USPTO publication date, most recent first